196 related articles for article (PubMed ID: 7987828)
1. Deletion of p16 and p15 genes in brain tumors.
Jen J; Harper JW; Bigner SH; Bigner DD; Papadopoulos N; Markowitz S; Willson JK; Kinzler KW; Vogelstein B
Cancer Res; 1994 Dec; 54(24):6353-8. PubMed ID: 7987828
[TBL] [Abstract][Full Text] [Related]
2. Homozygous deletions at chromosome 9p21 and mutation analysis of p16 and p15 in microdissected primary non-small cell lung cancers.
Packenham JP; Taylor JA; White CM; Anna CH; Barrett JC; Devereux TR
Clin Cancer Res; 1995 Jul; 1(7):687-90. PubMed ID: 9816033
[TBL] [Abstract][Full Text] [Related]
3. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
Heidenreich A; Gaddipati JP; Moul JW; Srivastava S
J Urol; 1998 May; 159(5):1725-30. PubMed ID: 9554401
[TBL] [Abstract][Full Text] [Related]
4. DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3-26.1 is deleted in malignant brain tumours.
Mollenhauer J; Wiemann S; Scheurlen W; Korn B; Hayashi Y; Wilgenbus KK; von Deimling A; Poustka A
Nat Genet; 1997 Sep; 17(1):32-9. PubMed ID: 9288095
[TBL] [Abstract][Full Text] [Related]
5. A methylthioadenosine phosphorylase (MTAP) fusion transcript identifies a new gene on chromosome 9p21 that is frequently deleted in cancer.
Schmid M; Sen M; Rosenbach MD; Carrera CJ; Friedman H; Carson DA
Oncogene; 2000 Nov; 19(50):5747-54. PubMed ID: 11126361
[TBL] [Abstract][Full Text] [Related]
6. Isolation and characterization of glioblastoma-associated homozygously deleted DNA fragments from chromosomal region 9p21 suggests involvement of multiple tumour suppressor genes.
Simons A; Jeuken JW; Eleveld MJ; Boerman RH; Geurts Van Kessel A
J Pathol; 1999 Nov; 189(3):402-9. PubMed ID: 10547603
[TBL] [Abstract][Full Text] [Related]
7. Deletion of p16INK4A/CDKN2 and p15INK4B in human somatic cell hybrids and hybrid-derived tumors.
Kuerbitz SJ; Malandro J; Compitello N; Baylin SB; Graff JR
Cell Growth Differ; 1999 Jan; 10(1):27-33. PubMed ID: 9950215
[TBL] [Abstract][Full Text] [Related]
8. Malignant astrocytomas with homozygous CDKN2/p16 gene deletions have higher Ki-67 proliferation indices.
Ono Y; Tamiya T; Ichikawa T; Kunishio K; Matsumoto K; Furuta T; Ohmoto T; Ueki K; Louis DN
J Neuropathol Exp Neurol; 1996 Oct; 55(10):1026-31. PubMed ID: 8857999
[TBL] [Abstract][Full Text] [Related]
9. Cell cycle regulators in bladder cancer: relationship to schistosomiasis.
Eissa S; Ahmed MI; Said H; Zaghlool A; El-Ahmady O
IUBMB Life; 2004 Sep; 56(9):557-64. PubMed ID: 15590562
[TBL] [Abstract][Full Text] [Related]
10. Human ependymomas reveal frequent deletions on chromosomes 6 and 9.
Huang B; Starostik P; Schraut H; Krauss J; Sörensen N; Roggendorf W
Acta Neuropathol; 2003 Oct; 106(4):357-62. PubMed ID: 12898154
[TBL] [Abstract][Full Text] [Related]
11. Infrequent alterations of the p15, p16, CDK4 and cyclin D1 genes in non-astrocytic human brain tumors.
Sato K; Schäuble B; Kleihues P; Ohgaki H
Int J Cancer; 1996 May; 66(3):305-8. PubMed ID: 8621248
[TBL] [Abstract][Full Text] [Related]
12. Somatic mutations of PTEN in glioblastoma multiforme.
Wang SI; Puc J; Li J; Bruce JN; Cairns P; Sidransky D; Parsons R
Cancer Res; 1997 Oct; 57(19):4183-6. PubMed ID: 9331071
[TBL] [Abstract][Full Text] [Related]
13. Frequent deletion and 5' CpG island methylation of the p16 gene in primary malignant lymphoma of the brain.
Zhang SJ; Endo S; Ichikawa T; Washiyama K; Kumanishi T
Cancer Res; 1998 Mar; 58(6):1231-7. PubMed ID: 9515810
[TBL] [Abstract][Full Text] [Related]
14. DCC expression is altered by multiple mechanisms in brain tumours.
Ekstrand BC; Mansfield TA; Bigner SH; Fearon ER
Oncogene; 1995 Dec; 11(11):2393-402. PubMed ID: 8570191
[TBL] [Abstract][Full Text] [Related]
15. [Chromosome anomalies in brain tumors].
Berthéas MF; Frappaz D; Elian J; Brizard C; Brunon J; Freycon F
Pediatrie; 1991; 46(1):65-9. PubMed ID: 1851285
[TBL] [Abstract][Full Text] [Related]
16. Deletions and rearrangements inactivate the p16INK4 gene in human glioma cells.
Srivenugopal KS; Ali-Osman F
Oncogene; 1996 May; 12(9):2029-34. PubMed ID: 8649864
[TBL] [Abstract][Full Text] [Related]
17. CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas.
Schmidt EE; Ichimura K; Reifenberger G; Collins VP
Cancer Res; 1994 Dec; 54(24):6321-4. PubMed ID: 7987821
[TBL] [Abstract][Full Text] [Related]
18. CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated.
Ueki K; Ono Y; Henson JW; Efird JT; von Deimling A; Louis DN
Cancer Res; 1996 Jan; 56(1):150-3. PubMed ID: 8548755
[TBL] [Abstract][Full Text] [Related]
19. Frequent and selective methylation of p15 and deletion of both p15 and p16 in T-cell acute lymphoblastic leukemia.
Batova A; Diccianni MB; Yu JC; Nobori T; Link MP; Pullen J; Yu AL
Cancer Res; 1997 Mar; 57(5):832-6. PubMed ID: 9041181
[TBL] [Abstract][Full Text] [Related]
20. High-resolution genomic copy number profiling of glioblastoma multiforme by single nucleotide polymorphism DNA microarray.
Yin D; Ogawa S; Kawamata N; Tunici P; Finocchiaro G; Eoli M; Ruckert C; Huynh T; Liu G; Kato M; Sanada M; Jauch A; Dugas M; Black KL; Koeffler HP
Mol Cancer Res; 2009 May; 7(5):665-77. PubMed ID: 19435819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
